Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

被引：0
|
作者：
Sam Razavi
Laurent Kodjikian
Audrey Giocanti-Aurégan
Ingrid Dufour
Eric Souied
机构：
[1] Centre d’Ophtalmologie,
[2] Centre Hospitalier de la Cr Rousse,undefined
[3] Université de Lyon,undefined
[4] Hôpital Avicenne,undefined
[5] AP-HP,undefined
[6] Université Paris 13,undefined
[7] DHU Vision et Handicaps,undefined
[8] Bayer HealthCare SAS,undefined
[9] Centre Hospitalier Intercommunal de Créteil,undefined
来源：
BMC Ophthalmology | / 21卷
关键词：
Retina; Age-related macular degeneration; Exudative; Switch; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Liza-Marie Marquis
    Irmela Mantel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1591 - 1596
  • [22] Efficacy of aflibercept in the second eyes of neovascular age-related macular degeneration patients who refractory to bevacizumab or ranibizumab in the first eyes
    Ma, Dae Joong
    Park, Un-Chul
    Yu, Hyeong Gon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [23] Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
    Griffin, David R.
    Richmond, Preston P.
    Olson, John C.
    JOURNAL OF OPHTHALMOLOGY, 2014, 2014
  • [24] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Alaa Din Abdin
    Shady Suffo
    Fatima Asi
    Achim Langenbucher
    Berthold Seitz
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1671 - 1677
  • [25] Intravitreal aflibercept in neovascular age-related macular degeneration with limited response to ranibizumab: a treat and extend trial
    Hatz, Katja B.
    Pruente, Christian
    Binningen, Vistaklinik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [26] Intravitreal ranibizumab versus aflibercept following treat and extend protocol for neovascular age-related macular degeneration
    Abdin, Alaa Din
    Suffo, Shady
    Asi, Fatima
    Langenbucher, Achim
    Seitz, Berthold
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (08) : 1671 - 1677
  • [27] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [28] Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
    Patel, K. H.
    Chow, C. C.
    Rathod, R.
    Mieler, W. F.
    Lim, J. I.
    Ulanski, L. J., II
    Leiderman, Y. I.
    Arun, V.
    Chau, F. Y.
    EYE, 2013, 27 (05) : 668 - 668
  • [29] Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept
    Calvo-Gonzalez, Cristina
    Reche-Frutos, Juan
    Ignacio Fernandez-Vigo, Jose
    Donate-Lopez, Juan
    Serrano-Garcia, Irene
    Fernandez-Perez, Cristina
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (11) : 2441 - 2448
  • [30] Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept
    Cristina Calvo-Gonzalez
    Juan Reche-Frutos
    José Ignacio Fernández-Vigo
    Juan Donate-López
    Irene Serrano-García
    Cristina Fernández-Pérez
    International Ophthalmology, 2019, 39 : 2441 - 2448
12345